Skip to main content
Figure 5 | Journal of Translational Medicine

Figure 5

From: Synergistic inhibition of human melanoma proliferation by combination treatment with B-Raf inhibitor BAY43-9006 and mTOR inhibitor Rapamycin

Figure 5

Phosphorylation of ERK in VMM18 melanoma cells treated with rapamycin, BAY43-9006, or U0126. The phosphorylation of ERK was analyzed by phosophosite-specific immunoblotting in VMM18 melanoma cells cultured and treated as described in Figure 4. The total amount of ERK protein was determined by immunoblotting with a separate antibody. The relative phosphorylation of ERK was quantitated by densitometry analysis using Image Quant 5.2 software and the values are given below the top panel.

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us